Australian company Endogene Ltd develops and commercialises medical technologies, including the Parascope self-propelling endoscope designed to advance through the gastrointestinal tract without conventional pushing. Its work also includes less-invasive vascular surgery systems, with products developed under an ISO 13485:2016 quality system and supported by an international patent portfolio. Endogene is an unlisted Australian public company funded through private investment, grants and R&D tax concessions.
ISO 13485:2016 Quality Standard for the Manufacture of Medical Devices
compliance_program